Reply to Letter: Using novel risk stratification statistics to better understand the value of screening tests

Int J Cancer. 2016 Oct 1;139(7):1669. doi: 10.1002/ijc.30192. Epub 2016 Jun 5.

Authors

Hormuzd A Katki¹, Fang-Hui Zhao^{1

2}, Shang-Ying Hu², Qian Zhang², You-Lin Qiao², Mark Schiffman¹

Affiliations

¹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD.
² Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, People's Republic of China.

PMID: 27184603
DOI: 10.1002/ijc.30192

No abstract available

Publication types

Letter
Research Support, N.I.H., Intramural
Comment

MeSH terms

Humans
Risk Assessment*